-
In this issue: FDA warnings for existing drugs dominate pharmaceutical news this month.
-
Previously, the recommendation in the United States for post-exposure prophylaxis of hepatitis A virus (HAV) infection has consisted of the administration of a single dose of immune serum globulin (ISG).
-
-
Though recent conflicting studies and commentaries have thoroughly confused the issue, the take-home message for infection control professionals which passes muster with all but the most strident critics is that the elderly should be immunized against seasonal influenza. Period.
-
Regardless of the current controversy regarding the efficacy of seasonal influenza vaccination in the elderly, it seems a given that seniors will fare much worse should a pandemic strain arise that eludes an immune response in all ages. But under closer scrutiny, that logic does not hold.
-
All the planets appear to be lining up to make a persuasive "business case" for infection control.
-
Hospitalizations related to methicillin-resistant Staphylococcus aureus (MRSA) infections more than doubled, from 127,000 to nearly 280,000, between 1999 and 2005, according to a new study.
-
The Centers for Disease Control and Prevention is responding to a recent Washington Post report that CDC estimates of new HIV infections in Americans annually may be 50% higher than previously believed.
-
Alarmed by continuing deaths and severe adverse reactions after treatment for latent tuberculosis, the Centers for Disease Control and Prevention is seeking funding approval for a national surveillance system to track the events.
-
